[A further clinical study of termination of early pregnancy by administration of long-acting dl-15-methyl-prostaglandin F2 alpha in combination with testosterone propionate (II)].
D000028:Abortion, Induced; D000728:Androgens; D001695:Biology; D002264:Carboxylic Acids; D055598:Chemical Phenomena; D002621:Chemistry; D004064:Digestive System; D004194:Disease; D004467:Economics; D004703:Endocrine System; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D006728:Hormones; D009930:Organic Chemicals; D010827:Physiology; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011453:Prostaglandins; D012098:Reproduction; D012102:Reproductive Control Agents; D012106:Research; D013672:Technology; D013739:Testosterone
D000728:Androgens; D002264:Carboxylic Acids; D006728:Hormones; D009930:Organic Chemicals; D011453:Prostaglandins; D012102:Reproductive Control Agents; D013739:Testosterone
Abortion, Induced; Androgens; Biology; Carboxylic Acids; Clinical Research; Diseases; Economic Factors; Endocrine System; Evaluation; Family Planning; Fertility Control, Postconception; Gastrointestinal Effects; Hormones; Ingredients And Chemicals; Organic Chemicals; Physiology; Pregnancy; Pregnancy, First Trimester; Prostaglandins--administraction and dosage; Reproduction; Reproductive Control Agents; Research And Development; Research Methodology; Technology; Testosterone--administraction and dosage